Overview

Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
To investigate efficacy and safety of pemetrexed combined with cisplatin for chemo-naive patients with Malignant Pleural Mesothelioma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Cisplatin
Pemetrexed